Alamar Biosciences Showcases Pioneering Brain-Derived pTau Data at the Alzheimer's Association International Conference

Alamar Biosciences, Inc. Ontario California

for a full list of posters and presentations featuring NULISA data during the AAIC meeting.

About Alamar Biosciences, Inc.

Alamar Biosciences is a privately held life sciences company with a mission to power precision proteomics to enable the earliest detection of disease. The company's proprietary NULISA Platform along with the ARGO HT System work seamlessly with the latest advances in genomics to achieve single digit attomolar detection sensitivity, greatly surpassing the most sensitive protein detection technology on the market today. For more information, please visit alamarbio.com.

Photo - https://mma.prnewswire.com/media/2738864/AAIC_2025_1.jpg
Logo - https://mma.prnewswire.com/media/1810182/Alamar_Logo_WhiteOutline_RGB_4x1_Logo_V1.jpg

View original content:https://www.prnewswire.co.uk/news-releases/alamar-biosciences-showcases-pioneering-brain-derived-ptau-data-at-the-alzheimers-association-international-conference-aaic-302514628.html